Press Releases Investors Overview News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts Company Info Overview Management Team Clinical Advisory Board Medical Consultants Presentations Contacts FAQ Financial Info Overview Balance Sheet Income Statement Cash Flow Financial Results Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Overview Board of Directors Board Committees Governance Documents Investor Tools Email Alerts Tear Sheet Investor Presentation Contacts RSS News Feed News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 All Releases Financial Releases Viveve Announces Reverse Stock Split to Regain NASDAQ Compliance Sep 18, 2019 Viveve to Present at the Ladenburg Thalmann 2019 Healthcare Conference Sep 17, 2019 Viveve to Present at the H.C. Wainwright 21st Annual Global Investment Conference Sep 3, 2019 Viveve Signs Exclusive Distribution Partnership with Paragon Meditech in Hong Kong, China and Macau Sep 3, 2019 Viveve Signs Exclusive Distribution Partnership in Canada with Salient Medical Solutions Aug 22, 2019 Viveve Reports Second Quarter 2019 Financial Results and Provides Corporate Update Aug 8, 2019 Viveve Reports Additional Clinical Results of LIBERATE-International Trial for Stress Urinary Incontinence Aug 7, 2019 Viveve to Host Conference Call to Provide Corporate Update and Second Quarter 2019 Results on August 8, 2019 Aug 1, 2019 Viveve Announces Top-line Results of LIBERATE-International Trial for SUI, Q2 Transition to New U.S. Commercial Model, and Pursuit of Financial and Strategic Alternatives Jul 22, 2019 Viveve Announces FDA 510(k) Clearance of Viveve 2.0 Next Generation System in the U.S. Jun 25, 2019 1 2 3 4 5 6 7 8 9 10 ...31
Viveve Signs Exclusive Distribution Partnership with Paragon Meditech in Hong Kong, China and Macau Sep 3, 2019
Viveve Signs Exclusive Distribution Partnership in Canada with Salient Medical Solutions Aug 22, 2019
Viveve Reports Additional Clinical Results of LIBERATE-International Trial for Stress Urinary Incontinence Aug 7, 2019
Viveve to Host Conference Call to Provide Corporate Update and Second Quarter 2019 Results on August 8, 2019 Aug 1, 2019
Viveve Announces Top-line Results of LIBERATE-International Trial for SUI, Q2 Transition to New U.S. Commercial Model, and Pursuit of Financial and Strategic Alternatives Jul 22, 2019
